Elanco Animal Health Incorporated — Form 8-K Summary
Reporting date: May 21, 2020; filed in connection with the company’s annual meeting of shareholders. The report was signed on May 22, 2020.
Business Context and Reporting Period
The filing reports the results of Elanco’s 2020 annual meeting of shareholders. It does not present quarterly or annual operating results.
Key Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics. As of the meeting record date, 398,799,023 shares of common stock were issued and outstanding.
Elanco’s common stock trades under the symbol ELAN, and its 5.00% Tangible Equity Units trade under ELAT, both on the New York Stock Exchange.
Material Matters and Voting Results
- Director elections: Michael J. Harrington, Deborah T. Kochevar, and Kirk P. McDonald were each elected to three-year terms ending at the 2023 annual meeting or until successors are elected and qualified.
- Independent auditor: Shareholders ratified Ernst & Young LLP as Elanco’s principal independent auditor for 2020, with 370,283,678 votes for, 42,172 against, and 123,225 abstentions.
- Executive compensation: Shareholders approved, on a non-binding basis, the compensation of named executive officers, with 342,233,849 votes for, 17,868,982 against, 327,581 abstentions, and 10,018,663 broker non-votes.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no management guidance, operating outlook, risk update, contingency disclosure, or unusual financial item. The principal matters disclosed are shareholder voting results and director appointments.
Important Facts to Verify
- Confirm the elected directors’ continued service and committee assignments following the annual meeting.
- Review subsequent filings for any changes to Elanco’s auditor, executive compensation, or corporate governance.
- Refer to Elanco’s quarterly and annual reports for financial performance, debt, liquidity, guidance, and COVID-19-related impacts, which are not addressed in this Form 8-K.